Minor to mild whole face atopic dermatitis, according to the severity classification of rash in the atopic dermatitis guideline of Japanese Dermatological Association.
Conditions
Interventions
Inspection such as observation, measurement and questionnaire before test start - Apply the test sample on whole face, two times in a day, in the morning and the evening, for two weeks - Inspection s
Sponsors
Inforward, inc EBISU skin research center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Those who satisfy all of the following conditions 1) Male aged 20 to 49. 2) Subjects who have minor to mild whole face atopic dermatitis, according to the severity classification of rash in the atopic dermatitis guideline of Japanese Dermatological Association. 3) Subjects who are using skin care product, such as facial wash, more than once in a day on their face in currently. 4) Subjects who show their willingness of participating to the test, and who obtain consent to participate in the test after understanding explanation of test.
Exclusion criteria
Exclusion criteria: 1) Subjects who have skin symptom such as moderate or higher atopic dermatitis, oral dermatitis, rosacea-like dermatitis. 2) Subjects who have trauma on the site of observation. 3) Subjects who have possibility to take a lot of sunlight such as daily sports at outside. 4) Subjects who have allergic symptoms against external medicine, cosmetic, quasi-drugs and others in the past. 5) Subjects who have severe hay fever. 6) Heavy alcohol drinker. 7) Subjects who have previous and/or current medical history of serious disease in liver, kidney, myocardial infarction. 8) Subjects who have severe anemia. 9) Subject who are going to hospital and being accepted medical treatment due to disease, except dentistry. 10) Persons who concern this test such as requester of this test and employee of trustee company. 11) Subjects who themselves and/or their family are working for a pharmaceutical companies and cosmetic companies. 12) Subjects who are participating in clinical tests, use tests and product monitor tests of medicines etc. And subjects who have been participated within 3 month in those tests described above. 13) Others who have been determined ineligible by investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Doctor's findings such as dryness or scales, erythema, papules, scratch marks on the face. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stratum corneum water content, transepidermal water transpiration amount, microscope photography, photography, questionnaire | — |
Countries
Japan
Contacts
Public ContactKazunori Takashima
Inforward, inc EBISU skin research center
Outcome results
None listed